mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.045 |
0.9 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |